{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:21:36Z","timestamp":1788459696138,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"12","funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The decades-long overdose epidemic in the United States is driven by opioid misuse. Overdoses commonly, although not exclusively, occur in individuals with opioid use disorder (OUD). To allocate adequate resources and develop appropriately scaled public health responses, accurate estimation of the prevalence of OUD is needed. Indirect methods (e.g., a multiplier method) of estimating prevalence of problematic substance-use behavior circumvent some limitations of household surveys and use of administrative data. We used a multiplier method to estimate OUD prevalence among the adult Medicaid population (ages 18\u201364 years) in 19 Ohio counties that are highly affected by overdose. We used Medicaid claims data and the US National Vital Statistics System overdose death data, which were linked at the person level. A statistical model leveraged opioid-related death rate information from a group with known OUD to estimate prevalence among a group with unknown OUD status given recorded opioid-related deaths in that group. We estimated that 13.6% of the total study population had OUD in 2019. Men (16.7%) had a higher prevalence of OUD than women (11.4%), and persons aged 35\u201354 had the highest prevalence (16.7%). Our approach to prevalence estimation has important implications for OUD surveillance and treatment in the United States.<\/jats:p>","DOI":"10.1093\/aje\/kwac154","type":"journal-article","created":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T09:28:24Z","timestamp":1661419704000},"page":"2098-2108","source":"Crossref","is-referenced-by-count":16,"title":["Opioid Use Disorder Among Ohio\u2019s Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method"],"prefix":"10.1093","volume":"191","author":[{"given":"Nathan J","family":"Doogan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Mack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushka","family":"Crane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Applegate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Villani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Redonna","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A","family":"Barocas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,8,25]]},"reference":[{"issue":"6408","key":"2025042804411087300_ref1","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","article-title":"Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016","volume":"361","author":"Jalal","year":"2018","journal-title":"Science."},{"issue":"11","key":"2025042804411087300_ref2","doi-asserted-by":"crossref","first-page":"290","DOI":"10.15585\/mmwr.mm6911a4","article-title":"Drug and opioid\u2013involved overdose deaths\u2014United States, 2017\u20132018","volume":"69","author":"Wilson","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"2025042804411087300_ref3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227966","article-title":"Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the Mortality Disparities in American Communities Study (MDAC)","volume":"15","author":"Altekruse","year":"2020","journal-title":"PLoS ONE."},{"key":"2025042804411087300_ref4","article-title":"Socioeconomic marginalization and opioid-related overdose: a systematic review","volume":"214","author":"Draanen","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"2025042804411087300_ref5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108329","article-title":"Addressing opioid overdose deaths: the vision for the HEALing communities study","volume":"217","author":"Chandler","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"5","key":"2025042804411087300_ref6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech-2018-210599","article-title":"Public health responses to the opioid crisis in North America","volume":"73","author":"Kerr","year":"2019","journal-title":"J Epidemiol Community Health."},{"key":"2025042804411087300_ref7","first-page":"18","article-title":"Estimating the prevalence of problematic drug use: a review of methods and their application","author":"Hickman","year":"2002","journal-title":"Bull Narc."},{"issue":"4","key":"2025042804411087300_ref8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1177\/0962280208094704","article-title":"Estimating the prevalence of ex-injecting drug use in the population","volume":"18","author":"Sweeting","year":"2009","journal-title":"Stat Methods Med Res."},{"issue":"4","key":"2025042804411087300_ref9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1177\/0962280208094701","article-title":"Estimating current injectors in Scotland and their drug-related death rate by sex, region and age-group via Bayesian capture\u2013recapture methods","volume":"18","author":"King","year":"2009","journal-title":"Stat Methods Med Res."},{"issue":"3","key":"2025042804411087300_ref10","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/jurban\/jth125","article-title":"Estimating numbers of injecting drug users in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for injecting drug users","volume":"81","author":"Friedman","year":"2004","journal-title":"J Urban Health."},{"issue":"suppl 2","key":"2025042804411087300_ref11","first-page":"ii11","article-title":"Counting hard-to-count populations: the network scale-up method for public health","volume":"86","author":"Russell Bernard","year":"2010","journal-title":"Sex Transm Infect."},{"key":"2025042804411087300_ref12","first-page":"93","article-title":"Economic impact of non-medical opioid use in the United States","author":"Davenport","year":"2019"},{"issue":"13","key":"2025042804411087300_ref13","first-page":"S243","article-title":"The economic burden of the opioid epidemic on states: the case of Medicaid","volume":"25","author":"Leslie","year":"2019","journal-title":"Am J Manag Care."},{"key":"2025042804411087300_ref14","author":"Department of Health and Human Services"},{"issue":"1","key":"2025042804411087300_ref15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ajad.12458","article-title":"Developing a research agenda for understanding the stigma of addictions part i: lessons from the mental health stigma literature","volume":"26","author":"Corrigan","year":"2017","journal-title":"Am J Addict."},{"issue":"1","key":"2025042804411087300_ref16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/10826084.2018.1496454","article-title":"The \u201creal\u201d number of Washington state adolescents using marijuana, and why: a misclassification analysis","volume":"54","author":"Murphy","year":"2019","journal-title":"Subst Use Misuse."},{"issue":"12","key":"2025042804411087300_ref17","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1111\/add.15111","article-title":"Estimating the prevalence of problem drug use from drug-related mortality data","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction."},{"key":"2025042804411087300_ref18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.socscimed.2018.09.005","article-title":"Validation of a new continuous geographic isolation scale: a tool for rural health disparities research","volume":"215","author":"Doogan","year":"2018","journal-title":"Soc Sci Med."},{"key":"2025042804411087300_ref19","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511790942","volume-title":"Data Analysis Using Regression and Multilevel\/Hierarchical Models","author":"Gelman","year":"2006","edition":"1st"},{"issue":"482","key":"2025042804411087300_ref20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1198\/016214508000000337","article-title":"The Bayesian lasso","volume":"103","author":"Park","year":"2008","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"2025042804411087300_ref21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/biomet\/asq017","article-title":"The horseshoe estimator for sparse signals","volume":"97","author":"Carvalho","year":"2010","journal-title":"Biometrika"},{"issue":"5","key":"2025042804411087300_ref22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s11222-016-9696-4","article-title":"Practical Bayesian model evaluation using leave-one-out cross-validation and WAIC","volume":"27","author":"Vehtari","journal-title":"Stat Comput."},{"key":"2025042804411087300_ref23","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Foundation for Statistical Computing","year":"2020"},{"key":"2025042804411087300_ref24","author":"Su","year":"2020"},{"key":"2025042804411087300_ref25","first-page":"1","volume-title":"Proceedings of the 3rd International Workshop on Distributed Statistical Computing","author":"Plummer","year":"2003"},{"key":"2025042804411087300_ref26","volume-title":"Behavioral Health Barometer: Ohio, Volume 5: Indicators as Measured Through the 2017 National Survey on Drug Use and Health and The National Survey of Substance Abuse Treatment Services","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"issue":"12","key":"2025042804411087300_ref27","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.2105\/AJPH.2018.304673","article-title":"Estimated prevalence of opioid use disorder in Massachusetts, 2011-2015: a capture-recapture analysis","volume":"108","author":"Barocas","year":"2018","journal-title":"Am J Public Health."},{"key":"2025042804411087300_ref28","volume-title":"Behavioral Health Barometer: United States, Volume 5: Indicators as Measured Through the 2017 National Survey on Drug Use and Health and The National Survey of Substance Abuse Treatment Services","author":"Substance Abuse and Mental Health Services Administration","year":"2019"},{"key":"2025042804411087300_ref29","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.039","article-title":"Touchpoints - opportunities to predict and prevent opioid overdose: a cohort study","volume":"204","author":"Larochelle","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2025042804411087300_ref30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","article-title":"Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths","volume":"200","author":"Barocas","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"2025042804411087300_ref31","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/0033354919878429","article-title":"The contribution of prescribed and illicit opioids to fatal overdoses in Massachusetts, 2013\u20132015","volume":"134","author":"Walley","year":"2019","journal-title":"Public Health Rep."},{"issue":"2","key":"2025042804411087300_ref32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/advance-article-pdf\/doi\/10.1093\/aje\/kwac154\/46498794\/kwac154.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/191\/12\/2098\/54650762\/kwac154.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/191\/12\/2098\/54650762\/kwac154.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T08:41:24Z","timestamp":1745829684000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/191\/12\/2098\/6675232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,25]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,8,25]]},"published-print":{"date-parts":[[2022,11,19]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/kwac154","relation":{},"ISSN":["0002-9262","1476-6256"],"issn-type":[{"value":"0002-9262","type":"print"},{"value":"1476-6256","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,8,25]]}}}